Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Completed × Erectile Dysfunction × Clear all

Phase

Phase NA 8 Phase 2 7 Phase 4 2 Phase 3 2 Phase 1/2 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 226 Neoplasms 185 Carcinoma, Non-Small-Cell Lung 185 Leukemia, Myeloid, Acute 165 Multiple Myeloma 146 Colorectal Neoplasms 142 Melanoma 137 Prostatic Neoplasms 134 Lymphoma 122 Leukemia 121 Glioblastoma 115 Pancreatic Neoplasms 109 Lymphoma, Non-Hodgkin 109 Lung Neoplasms 102 Neoplasm Metastasis 101 Ovarian Neoplasms 96 Leukemia, Lymphocytic, Chronic, B-Cell 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 91 Myelodysplastic Syndromes 80 Hodgkin Disease 80 Recurrence 75 Lymphoma, Large B-Cell, Diffuse 74 Lymphoma, Follicular 72 Brain Neoplasms 68 Lymphoma, Mantle-Cell 67 Head and Neck Neoplasms 66 Carcinoma, Renal Cell 66 Carcinoma, Hepatocellular 64 Colonic Neoplasms 61 Glioma 57

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡